COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03053466
Recruitment Status : Active, not recruiting
First Posted : February 15, 2017
Last Update Posted : June 6, 2019
Novotech (Australia) Pty Limited
Apollomics Inc. (formerly CBT Pharmaceuticals, Inc.)
Information provided by (Responsible Party):
Apollomics (Australia) Pty. Ltd.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : December 2021